EFSCE
ALDR

Enterprise Financial Services Corp (EFSC)’s Alder Biopharmaceuticals ALDR Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-47
Closed -$2K – 1172
2015
Q2 		$2K Buy
+47
New +$1.71K ﹤0.01% 951

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s ALDR Position: Q3 2015 in Review

Enterprise Financial Services Corp (EFSC) sold out of Alder Biopharmaceuticals (ALDR) in Q3 2015, closing a stake of 47 shares — an estimated $2K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in ALDR in Q2 2015 and held it in 1 quarter. The position peaked at $2K in Q2 2015. 140 funds tracked by Wall St. Rank hold ALDR as of Q3 2015.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Alder Biopharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 47 Alder Biopharmaceuticals shares in Q3 2015, an estimated $2K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Enterprise Financial Services Corp (EFSC)'s Alder Biopharmaceuticals position peaked at $2K in Q2 2015.
  • 140 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2015.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2015, filed 29 Oct 2015.